Cheryl A. Madsen
Consejero General en VIRACTA THERAPEUTICS, INC. .
Cargos activos de Cheryl A. Madsen
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Consejero General | - | - |
Historial de carrera de Cheryl A. Madsen
Antiguos cargos conocidos de Cheryl A. Madsen.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PELOTON THERAPEUTICS, INC. | Consejero General | - | - |
| Medivation, Inc. /Old/ | Corporate Officer/Principal | - | - |
| CALITHERA BIOSCIENCES, INC. | Consejero General | - | - |
Formación de Cheryl A. Madsen.
| University of California, Santa Cruz | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| General Counsel | 3 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
- Bolsa de valores
- Insiders
- Cheryl A. Madsen
- Experiencia
